Case 2
A 70-year-old woman attended our dermatology clinic with diffuse skin eruptions of one month duration. She complained of a progressive maculopapular rash beginning from the arms, and extending to all the body surface, with gradual stiffness of the lesions. She acknowledged that the condition started 2 days after getting the first dose of AstraZeneca SARS-CoV-2 vaccine. Physical examination revealed multiple sclerotic skin eruptions all over the body including intertriginous areas (figure 2). Deep skin biopsy revealed scledermoid changes. Her polymerase chain reaction (PCR) test for SARS-CoV-2 was reported negative. Other laboratory tests including complete rheumatology panel were normal. Tumor markers and other assessments for malignancies also did not reveal an underlying cancer. Our patient refused to undergo phototherapy, so we started her on methotrexate and topical corticosteroids and are waiting to see the response.